We use cookies to ensure that we give you the best experience on our website Learn more

Home

Saved research

Nov 3, 2019

International Diabetes Federation Congress 2019

Diabetes in rural areas of Cambodia with T2DM in Kampong Cham Provincial Referral Hospital

diabetes in rural areas

cambodia with diabetes type2

kampong cham with diabetes

Abstract

44

Views

44

Views

Abstract

Fullscreen

thumbnail

Keywords

diabetes in rural areas

cambodia with diabetes type2

kampong cham with diabetes

Abstract

Introduction Diabetes is a public health problem. Its prevalence increases in developing countries. Diabetes has a high prevalence due to a genetic predisposition associated with a rapid change in lifestyles. World Health Organization pronounced that globally, approximately 422 million people have Diabetes Mellitus (MD). Particularly, those who are living in low and low-middle income countries (WHO, 2019). Non-Communicable diseases kill 41 million people each year, equivalent to 71 % of all deaths globally, and diabetes 1.6 million (WHO, 2018). Objective This study is conducted in order to find the population living in rural areas with T2DM on early diagnosed Diabetes Mellitus patients who came to have consultation and treatment with doctors at Kampong Cham Provincial Referral Hospital. Method The reports of 803 patients were collected in Kampong Cham Provincial Referral Hospital for the period of 12 months (January 1, 2018, to January 1, 2019). All patients included in this study have been undergone the following examinations and categorized according to gender, ages, weight, height, BMI value, level of glycemia and HbA1c Results The study consists of 803 cases (male: 35%, woman: 65%). The median age of our patients is 57 years old (Between 35 and 81); the most interested age group is 46-56. Contributing factors to T2DM are the fact that patients had no knowledge of diabetic (85%). Most patients are cultivators (63%). The main reason for consultation is asthenia (94%), followed by paresthesia of extremities (71%), polyuria (65%), polydipsia (45%), visual blur (45%), weight loss (29%) and general state alteration (11%). The main complications found were diabetic retinopathy (55%), high blood pressure (53%), chronic renal failure (52%) and diabetic neuropathy (3%). Oral antidiabetic treatment is represented by glibenclamide 10%, metformin 60%, and the combination of glibenclamide and metformin 30%.

Company

Legal

Follow us

© Copyright 2019 Morressier GmbH. All rights reserved.

© Copyright 2019 Morressier GmbH.
All rights reserved.